Immunogenicity studies for the coronavirus vaccines: How to stay on track and...
As the world waits for a vaccine to protect against COVID-19, the disease caused by the novel coronavirus, it will need not only scientific excellence but also business continuity excellence to keep...
View ArticlePesticide active ingredient renewal: how to negotiate the EU endocrine...
ED assessment of active substances in PPPs came into effect in November 2018 in the EU. Insights from EFSA’s assessment of the first 65 actives shows how guidance is applied and how waivers are being...
View Article
More Pages to Explore .....
